Susanna S Ng

10PUBLICATIONS
46CO-AUTHORS
Molecular targetsCellular nervous systemPredictive and prognostic markersInnate immunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 09, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Feb 15, 2024
Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Susanna S Ng, Fabian De Labastida Rivera, Juming Yan

|Mar 25, 2022
CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC.

Christine Sanders, Almotasem Salah M Hamad, Susanna Ng

|Jan 11, 2022
NKG7 Is Required for Optimal Antitumor T-cell Immunity.

Xian-Yang Li, Dillon Corvino, Bianca Nowlan

|Nov 12, 2021
A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment.

Susanna S Ng, Sonia Leonardelli, Michael Hölzel

Pageof 2